
Protect Pharmaceutical
(OTC) PRTT
Protect Pharmaceutical Financials at a Glance
Market Cap
$2.87M
Revenue (TTM)
$112.39M
Net Income (TTM)
$49.34M
EPS (TTM)
$0.86
P/E Ratio
0.06
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$0.05
Volume
77,611
Open
$0.06
Price
$0.05
Volume
77,611
Open
$0.06
Previous Close
$0.05
Daily Range
$0.05 - $0.06
52-Week Range
$0.02 - $1.50
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$0.05
Volume
77,611
Open
$0.06
Previous Close
$0.05
Daily Range
$0.05 - $0.06
52-Week Range
$0.02 - $1.50
PRTT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Protect Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareCEO
Ozgur Ozcan
Website
www.protectpharma.comHeadquarters
Las Vegas, NV 89115, US
PRTT Financials
Key Financial Metrics (TTM)
Gross Margin
55%
Operating Margin
34%
Net Income Margin
28%
Return on Equity
15%
Return on Capital
8%
Return on Assets
5%
Earnings Yield
16.67%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.87M
Shares Outstanding
57.45M
Volume
77.61K
Short Interest
0.00%
Avg. Volume
8.10K
Financials (TTM)
Gross Profit
$72.56M
Operating Income
$57.64M
EBITDA
$57.64M
Operating Cash Flow
$12.71M
Capital Expenditure
$2.52M
Free Cash Flow
$10.19M
Cash & ST Invst.
$73.94M
Total Debt
$3.83M
Protect Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$26.34M
-42.1%
Gross Profit
$14.67M
-29.5%
Gross Margin
55.70%
N/A
Market Cap
$2.87M
N/A
Market Cap/Employee
$957.53K
N/A
Employees
3
N/A
Net Income
$6.63M
-50.8%
EBITDA
$8.84M
-34.4%
Quarterly Fundamentals
Net Cash
$71.36M
+20.6%
Accounts Receivable
$60.64M
-12.7%
Inventory
$124.77M
+50.3%
Long Term Debt
$0.00
N/A
Short Term Debt
$4.41M
+14.1%
Return on Assets
5.49%
N/A
Return on Invested Capital
8.05%
N/A
Free Cash Flow
$4.57M
-276.9%
Operating Cash Flow
$2.10M
-181.3%